对严重喘生物药物反应的预测因素:系统审查和元分析
Anna Rattu1,2, Piers Dixey3,4, David Charles5
1Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Allergy
|September 16, 2025
概括
确定治疗严重喘的最佳生物药物至关重要. 较高的血中乙氨基酸细胞数量,FeNO水平,较低的口服皮质类固醇使用,以及更好的喘控制预测了对生物药物的积极反应.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物学家为严重喘提供有效的治疗方法.
- 患者对生物制剂的反应有很大差异.
- 预测哪种生物药物对个体患者最有效仍然是一个挑战.
研究的目的:
- 系统地确定严重喘中对生物制剂 (不包括奥马利祖马布) 的反应预测因子.
- 综合有关与生物治疗疗效相关的患者特征的证据.
- 评估已识别的预测因素的证据质量.
主要方法:
- 在四个数据库和两个试验注册表 (1990-2024) 中进行系统的文献搜索.
- 数据提取和偏差风险评估由两个独立审稿人进行.
- 叙事综合和元分析 (如适用),并进行GRADE确定性评估.
主要成果:
- 中等到高质量的证据表明,血中异氨基酸细胞数量升高 (≥300细胞/μL),FeNO水平高 (>40ppb),口服皮质类固醇 (OCS) 使用低或不使用 (<10 mg/天),以及更好的喘控制预测了生物反应.
- 对其他预测因素的证据有限,质量低.
- 对于儿科群体或非T2通路生物体没有发现数据.
结论:
- 血中乙氨基酸细胞数量,FeNO水平,OCS剂量和喘控制是严重喘生物反应的关键预测因素.
- 需要进一步的研究来确定普遍适用的预测因素,特别是对于非T2向疗法和儿科患者.
- 响应定义中的异质性和不准确性限制了许多预测器的证据确定性.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
23.3K
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
31.8K
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K